Accuray Inc
SWB:XEJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Accuray Inc
SWB:XEJ
|
US |
|
Q
|
QinetiQ Group PLC
F:QY6
|
UK |
|
R
|
Republic Services Inc
F:RPU
|
US |
|
Greenyard NV
F:2P1
|
BE |
|
Lineage Cell Therapeutics Inc
F:BT3
|
US |
|
U
|
United Therapeutics Corp
XMUN:UTH
|
US |
|
Vertiv Holdings Co
F:49V
|
US |
|
L
|
Lineage Cell Therapeutics Inc
TASE:LCTX
|
US |
|
W
|
Wasco Bhd
KLSE:WASCO
|
MY |
Wall St Price Targets
XEJ Price Targets Summary
Accuray Inc
According to Wall Street analysts, the average 1-year price target for XEJ is 0.294 EUR with a low forecast of 0.292 EUR and a high forecast of 0.303 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XEJ's stock price target?
Price Target
0.294
EUR
According to Wall Street analysts, the average 1-year price target for XEJ is 0.294 EUR with a low forecast of 0.292 EUR and a high forecast of 0.303 EUR.
What is the Revenue forecast for Accuray Inc?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is -2%.
What is the Gross Profit forecast for Accuray Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 3 years is 10%.
What is the Operating Income forecast for Accuray Inc?
Projected CAGR
24%
The compound annual growth rate for Operating Income over the next 3 years is 24%.
What is the Pre-Tax Income forecast for Accuray Inc?
Projected CAGR
153%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 153%.
